×
111 Share Holder Equity 2018-2024 | YI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
111 share holder equity from 2018 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
View More
111 Share Holder Equity 2018-2024 | YI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
111 share holder equity from 2018 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$11.4B
Inspire Medical Systems (INSP)
$5.9B
Hims & Hers Health (HIMS)
$5B
Axonics (AXNX)
$3.6B
IRhythm Technologies (IRTC)
$2.7B
Enovis (ENOV)
$2.6B
Privia Health (PRVA)
$2.5B
Omnicell (OMCL)
$2.3B
Azenta (AZTA)
$2.2B
10x Genomics (TXG)
$1.9B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.2B
Standard BioTools (LAB)
$800M
Fulgent Genetics (FLGT)
$589M
Butterfly Network (BFLY)
$558M
Talkspace (TALK)
$555M
Definitive Healthcare (DH)
$500M
Health Catalyst (HCAT)
$498M
Pulmonx (LUNG)
$294M
SOPHiA GENETICS SA (SOPH)
$230M
TruBridge (TBRG)
$203M
American Well (AMWL)
$135M
P3 Health Partners (PIII)
$134M
EUDA Health Holdings (EUDA)
$108M
HeartBeam (BEAT)
$68M
Future Health ESG (FHLT)
$65M
Zepp Health (ZEPP)
$49M
SHL Telemedicine (SHLT)
$45M
CareCloud (CCLD)
$44M